Trial Profile
MK0767 Glipizide Comparator Cardiac Safety Study (0767-018)
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 06 May 2022
Price :
$35
*
At a glance
- Drugs MK 0767 (Primary) ; Glipizide
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Registrational
- Sponsors Merck Sharp & Dohme
- 01 Mar 2014 New trial record